Acceleron Pharma Inc
Change company Symbol lookup
Select an option...
XLRN Acceleron Pharma Inc
SDY SPDR® S&P Dividend ETF
DIS Walt Disney Co
AAPL Apple Inc
MLM Martin Marietta Materials Inc
GOOG Alphabet Inc
FCNTX Fidelity® Contrafund® Fund
MSFT Microsoft Corp
GLPG Galapagos NV
FLR Fluor Corp
Go

Health Care : Biotechnology | Mid Cap Growth
Company profile

Acceleron Pharma Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its research focuses on key natural regulators of cellular growth and repair, particularly the Transforming Growth Factor-Beta (TGF-beta), protein superfamily. It has four internally discovered therapeutic candidates that are in clinical trials, which include luspatercept, sotatercept, dalantercept and ACE-083. It offers a platform technology, IntelliTrap. It is also evaluating ACE-1332, a selective TGF-beta antagonist, for treatment of disorders with a fibrotic component, and additional molecules from its IntelliTrap platform for undisclosed therapeutic areas. Dalantercept is designed to treat cancers by inhibiting blood vessel formation by inhibiting signaling through the ALK1 receptor. ACE-083 is designed to promote muscle growth and function in specific, targeted muscles.

Price
Delayed
$120.64
Day's Change
-1.19 (-0.98%)
Bid
--
Ask
--
B/A Size
--
Day's High
123.10
Day's Low
118.96
Volume
(Light)

Today's volume of 74,698 shares is on pace to be much lighter than XLRN's 10-day average volume of 358,892 shares.

74,698
  • Prev Close
    121.83
  • Today's Open
    122.28
  • Day's Range
    118.96-123.10
  • Avg Vol (10-day)
    358.9K
  • Last (time)
    11:21a ET 05/07/21
  • Last (size)
    100
  • 52-Wk Range
    85.58 - 146.15
    LowHigh
  • (09/04/20 - 03/22/21)
    17.45%
  • 41.3%
  • Market Cap
    7.3B
  • Shares Outstanding
    60.7M
  • -2.91
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.4
  • 88.33
  • (% of float 04/15/21)
    4.48

Latest News

May 06, 2021
4:35 pm ET
Zacks
4:01 pm ET
BusinessWire
2:48 pm ET
Accesswire
April 29, 2021
4:04 pm ET
Zacks
7:10 am ET
BusinessWire
April 26, 2021
7:00 am ET
BusinessWire
April 05, 2021
7:00 am ET
BusinessWire
April 01, 2021
7:00 am ET
BusinessWire
March 23, 2021
9:51 am ET
MarketWatch
February 25, 2021
4:01 pm ET
BusinessWire
2:45 pm ET
Accesswire
February 23, 2021
10:27 am ET
Zacks
7:00 am ET
BusinessWire
February 17, 2021
7:00 am ET
BusinessWire
February 16, 2021
7:37 am ET
BusinessWire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.